3,3',4'-trihydroxyflavone has been researched along with 10,10'-dimethyl-9,9'-biacridinium in 1 studies
Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (10,10'-dimethyl-9,9'-biacridinium) | Trials (10,10'-dimethyl-9,9'-biacridinium) | Recent Studies (post-2010) (10,10'-dimethyl-9,9'-biacridinium) |
---|---|---|---|---|---|
39 | 0 | 22 | 500 | 7 | 43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Malakul, W; Woodman, OL | 1 |
1 other study(ies) available for 3,3',4'-trihydroxyflavone and 10,10'-dimethyl-9,9'-biacridinium
Article | Year |
---|---|
3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta.
Topics: Acridines; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Flavonols; In Vitro Techniques; Luminescence; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides | 2009 |